Literature DB >> 1629611

A simple enzyme-linked immunosorbent assay (ELISA) for the neuron-specific gamma isozyme of human enolase (NSE) using monoclonal antibodies raised against synthetic peptides corresponding to isozyme sequence differences.

M E Duncan1, S M McAleese, N A Booth, W T Melvin, J E Fothergill.   

Abstract

Monoclonal antibodies specific for the gamma isozyme of human enolase (known as neuron-specific enolase or NSE) have been raised against synthetic peptides after coupling to carrier protein: the selected peptides were those corresponding to regions of amino acid sequence difference between the alpha and gamma subunits of these closely similar isozymes. This technique gave monoclonal antibodies of high specificity and affinity. Two monoclonal antibodies raised against different peptides were used to develop a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA), using one as the solid-phase antibody and the other conjugated to horseradish peroxidase to detect the bound NSE. This assay provides a simple and routine method of detecting NSE in serum samples from patients with small-cell carcinoma of the lung and related tumours.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629611     DOI: 10.1016/0022-1759(92)90121-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Matrix metalloproteinases and their inhibitors in gastric cancer.

Authors:  G I Murray; M E Duncan; E Arbuckle; W T Melvin; J E Fothergill
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

2.  Immunohistochemistry of neurone specific enolase with gamma subunit specific anti-peptide monoclonal antibodies.

Authors:  G I Murray; M E Duncan; W T Melvin; J E Fothergill
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

3.  The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance.

Authors:  Abdo Alnabulsi; Rebecca Swan; Beatriz Cash; Ayham Alnabulsi; Graeme I Murray
Journal:  Br J Cancer       Date:  2017-05-30       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.